Best Life Sciences Companies in Auckland, New Zealand
The 54 best Life Sciences companies in Auckland, New Zealand in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Pictor.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Auckland
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Pictor Developer of immunodiagnostic products based on multiplexed assays | $11M | 9 mo ago | Series A | Wanda Mathias Co-Founder | 2005 | WebflowreCAPTCHAHSTS+10 | 27 patents Multiplex serological immunoassays for detecting antibodies against viruses and bacterial pathogens | 1 award |
| 2 | Toku Eyes Developer of AI-powered retinal image analysis for early disease detection. | $11M | 39 mo ago | Acquired | David Squirrell Co-Founder | 2018 | WordPressApple iCloud MailGoogle Workspace+28 | 13 patents Automated retinal fundus image analysis for eye disease detection and prognosis | — |
| 3 | Kitea Health Developer of a medical device for the monitoring of pressure | $10M | 40 mo ago | Seed | — | 2021 | WixSentryEnvoy+14 | — | 1 partnership |
| 4 | Therapy Cells Commercializing tissue transplantation technology for regenerative medicine | $6M | 129 mo ago | Deadpooled | Christopher Glover CEO | 2007 | — | — | — |
| 5 | Scentian Bio: Developer of biosensor technology using insect odorant receptors for real-time sensing | $4M | 3 mo ago | Seed | Andrew Kralicek Co-Founder & Chief Technology Officer | 2020 | Cart FunctionalitySquarespace CommerceSquarespace+15 | 9 patents Portable biosensor devices for detecting biological analytes using electrochemical sensing | — |
| 6 | Kahu AI-based skin cancer diagnosis solutions for dermatologists | $3M | 60 mo ago | Seed | Stuart Dalrymple CEO | 2021 | — | 4 patents Patents concentrated in computing, sensing & instrumentation | — |
| 7 | Upside Biotechnologies Developer of regenerative medicine for treating burns | $2M | 111 mo ago | Series A | — | 2016 | — | 3 patents Formulation of specialized cell culture media for bioproduction | — |
| 8 | Genesis Specialty company developing treatment for the treatment of cancer | $2M | 362 mo ago | Deadpooled | James Douglas Watson Founder | 1994 | — | — | — |
| 9 | Avasa Developer of an implantable device for surgeries | $2M | 10 mo ago | Seed | Nandoun Abeysekera Founder & CEO | 2018 | — | 5 patents Medical tubular tissue engineering devices for minimally invasive fluid delivery | — |
| 10 | RespirAq Developer of a medical humidification device for respiration | $2M | 53 mo ago | Seed | Sandra Bartual Founder & CEO | 2020 | — | — | — |
| 11 | Helico Provider of computational modeling tool | $1M | 50 mo ago | Seed | — | 2020 | — | — | — |
| 12 | Breathe Easy Therapeutics Specially formulated therapeutics for cystic fibrosis | $1M | 133 mo ago | Deadpooled | Andrea Miller CEO | 2009 | — | — | — |
| 13 | Veriphi Laser verification system to prevent injuries and death caused by IV systems | $737K | 114 mo ago | Seed | Gregory Joseph Shanahan Co-Founder & MD | 2015 | — | 10 patents Specialized sample containers for spectrophotometric analysis | — |
| 14 | Junofem Developer of a smart device for screening urinary incontinence | $694K | 57 mo ago | Seed | — | 2018 | Cart FunctionalityShopifySentry+19 | — | — |
Top 12 Life Sciences companies in Auckland
#1
Seed · Auckland, Auckland · founded 2020 · 7 employees$4.4Mraised▾
Developer of biosensor technology using insect odorant receptors for real-time sensing. The company synthesizes insect odorant receptors to create biosensors. These biosensors measure the concentration of compounds. The technology provides insights for food, health, and environmental monitoring. The company combines synthetic biology with artificial intelligence for sensing applications.
- Apr 2026Seed$7M
- Sep 2023Seed$2.1M
- Nov 2022Grant (prize money)$1.7M
- Jan 2021Seed$1M
#2
Series A · Auckland, Auckland · founded 2005 · 51 employees$11.1Mraised▾
Developer of immunodiagnostic products based on multiplexed assays. The proprietary PixArray technology has an array of dots that contain the required reagents, with each panel also containing control dots. The assay panel requires only 20 microliters of blood for accurate diagnosis. In addition, the company has also developed an imaging software called Pictimager and analysis software called Pictorial to enable automated immunoassays.
- Sep 2025Series A—
- Dec 2022Series A$5M
- Apr 2022Series A$6.1M
- May 2020Grant (prize money)$300K
#3
Seed · Auckland, Auckland · founded 2018 · 2 employees$1.6Mraised▾
Developer of an implantable device for surgeries. It offers Coupler that allow surgeons to connect both arteries and veins in reconstructive microsurgery.
- Aug 2025Seed$2.8M
- Sep 2023Seed$1.6M
#4
Acquired · Auckland, Auckland · founded 2018 · 14 employees$10.5Mraised▾
{}
- Apr 2023Series A$8M
- Jun 2021Seed$2.5M
- Grant (prize money)—
#5
Seed · Auckland, Auckland · founded 2021 · 18 employees$9.7Mraised▾
Developer of a medical device for the monitoring of pressure. It offers an implantable device integrated with software that can receive power and send data to a communication rod through flesh and bone for the management of hydrocephalus.
- 2023Grant (prize money)$14M
- Feb 2023Seed$3.7M
- Sep 2022Seed$6M
#6
Seed · Auckland, Auckland · founded 2021 · 7 employees$3Mraised▾
AI-based skin cancer diagnosis solutions for dermatologists. The platform provides decision-support solutions for doctors using the skin image database that provides diagnoses for a broad range of skin cancers. The technology assists primary care physicians in screening programs and clinical tests.
- Jul 2021Seed$3M
#7
Deadpooled · Auckland, Auckland · founded 2007$5.7Mraised▾
Therapy Cells is a biotech company commercializing a novel and efficient method for growing tendon and articular cartilage for autotransplantation into patients. The company's method can be applied to other tissues as well, such as pancreatic or cardiac tissue and offers the advantage of the absence of immune rejection of the transplanted cells on account of being autologous. The company has licensed its technology for transplantation of granulosa cells for use in the non-surgical sterilization of dogs and cats.
- Sep 2015Grant (prize money)$5.7M
#8
Seed · Auckland, Auckland · founded 2020 · 4 employees$1.5Mraised▾
Developer of a medical humidification device for respiration. It offers a heated humidifier device integrated with a filter that humidifies and switches between a super-hydrophilic state and a super-hydrophobic state to capture moisture during expiration and inspiration for for ventilated humidification.
- Jan 2022Seed$1.5M
#9
Seed · Auckland, Auckland · founded 2020 · 8 employees$1.3Mraised▾
Provider of computational modeling tool. It provides a modeling tool for drug discovery and development. The tool enables users to analyze and predict the biochemical interaction in plants.
- May 2022Seed$1.3M
#10
Series A · Auckland, Auckland · founded 2016 · 4 employees$2.3Mraised▾
Upside Biotechnologies is developing regenerative medicine for the treatment of burns. The regenerative medicine developed is called PelliCel that is developed using the proprietary process by taking a piece of the burnt tissue to regenerate it into multiple sheets. The company is yet to complete phase I trials for PelliCel.
- Mar 2017Series A$2.3M
#11
Deadpooled · Auckland, Auckland · founded 1994$1.9Mraised▾
Specialty company developing treatment for the treatment of cancer
#12
Seed · Auckland, Auckland · founded 2018 · 9 employees$694.1Kraised▾
Developer of a smart device for screening urinary incontinence. The device femfit measures the pressure profile of the vagina. This is used to assist women to perform pelvic floor exercises, improve pelvic floor health and reduce the symptoms of urinary incontinence.
- Oct 2021Seed$694.1K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
What Auckland researches in biotechnology
University of Auckland and Auckland University of Technology lead recent RNA regulation, amyloidosis, and phytochemical research with an optimistic tone, dominated by breakthroughs since 2020.
- University of Auckland10
- Auckland University of Technology6
- Auckland City Hospital1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.